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Abstract
It has been estimated that up to 30% of detectable polyps in patients regress spontaneously. One major challenge in the
evaluation of effective therapy of cancer is the readout for tumor regression and favorable biological response to therapy.
Inducible near infra-red (NIR) fluorescent probes were utilized to visualize intestinal polyps of mice hemizygous for a novel
truncation of the Adenomatous Polyposis coli (APC) gene. Laser Scanning Confocal Microscopy in live mice allowed visualization
of cathepsin activity in richly vascularized benign dysplastic lesions. Using biotinylated suicide inhibitors we quantified increased
activities of the Cathepsin B & Z in the polyps. More than L of the probe signal was localized in CD11b
+Gr1
+ myeloid derived
suppressor cells (MDSC) and CD11b
+F4/80
+ macrophages infiltrating the lesions. Polyposis was attenuated through genetic
ablation of cathepsin B, and suppressed by neutralization of TNFa in mice. Inbothcases, diminished probe signal was accounted
for by loss of MDSC. Thus, in vivo NIR imaging of focal cathepsin activity reveals inflammatory reactions etiologically linked with
cancer progression and is a suitable approach for monitoring response to therapy.
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Introduction
Colonic and intestinal adenocarcinomas arise as a direct result
of the loss of function of the adenomatous polyposis coli (APC)
gene and stabilization of b-catenin. Rodent models of hereditary
colon cancer faithfully reproduce the histopathology of familial
adenomatous polyposis coli (FAP) [1,2] and provide opportunities
for investigating secondary events that modulate genetic predis-
position to colon cancer [3]. Accumulating evidence suggests that
inflammation has causative roles in carcinogenesis [4]. While
chronic inflammation can predispose to DNA damage and
carcinogenesis, there is evidence to suggest that inflammation is
a necessary component of tumor growth. In line with this notion,
treatment of APC defective Min mice [5] with cyclooxigenase-2
(COX2) inhibitors results in a transient suppression of polyposis
[6,7], an observation that parallels the response of colon cancer
patients to similar treatments [8]. Furthermore, anti-TNFa, or the
transfer of CD4
+CD25
+CD45RB
low regulatory T (Treg) cells,
both hinder polyp growth in mice [9]. Together these observations
strongly argue in favor of a causative link between inflammatory
reactions and genetically induced colon cancer, opening possibil-
ities for monitoring and targeting cancer associated inflammation
for diagnostic and therapeutic purposes.
Proteolytic enzymes play essential roles in tumor growth,
angiogenesis, and invasion. Cathepsins of the cysteine protease
family and in particular cathepsin-B are commonly active in the
tumor microenvironment, contributing to the regulation of
angiogenesis and invasion during cancer progression [10,11].
We have shown that optical in vivo imaging of cathepsin B activity
using near infra-red mechanism-based probe allows for highly
sensitive detection of adenomatous polyps in mice with direct
reflectance imaging [12,13]. The cathepsin inducible fluorescent
probe (ProSense 680) is a composite polymer containing a poly-L-
lysine backbone; on which quenched NIR (excitation 675 nm,
emission 694 nm) fluorophore and several polyethyleno-glycol
side-chains are attached. ProSense 680 is preferentially hydrolyzed
by cathepsin B, but it can be activated through proteolysis by other
cathepsins and other related proteases [14]. Using this approach,
mouse polyps were specifically revealed by reflectance imaging
[13,14,15] and by in vivo fluorescence endoscopy [16]. However,
the cellular source of signal and biological meaning of the protease
activity has remained enigmatic.
Here we used targeted in vivo analysis of cysteine cathepsins with
ProSense 680. To investigate how specifically the probe activity
demarcates areas of dysplasia and the relevance of probe signal to
biological activity within the tumor we used the prototype
PLoS ONE | www.plosone.org 1 August 2008 | Volume 3 | Issue 8 | e2916Olympus IV 100 scanning LASER intravital microscope to image
intestinal lesions in a new mouse model of hereditary polyposis,
APC
D468 mice. We report that probe activation reflects the local
density of pro-inflammatory cells infiltrating the lesion and
amount of associated active enzyme at the tumor site. Further-
more, using cathepsin B deficient APC
D468 (Ctsb
2/2 APC
D468)
mice, as well as, anti-inflammatory treatments, we provide
evidence for a causative link between protease activity, inflamma-
tion and polyp growth. Altogether, the present study shows that
NIR imaging of pre-neoplastic lesions using near infra red
mechanism-based probes is a viable approach to detect biological
activities etiologically connected with progressive tumor growth,
and provides opportunities for monitoring biological response to
effective therapy.
Results
Mouse APC
D468 Model: Morphology and Histopathology
of Adenomatous Polyps
A novel model of hereditary polyposis was generated by
targeted deletion of exons 11 and 12 of the adenomatous polyposis
coli (APC), causing truncation of the gene product at codon 468.
The resulting mice (APC
D468) were backcrossed to C57BL/6J for
at least 12 generations. Adenomatous polyps were found in
abundance in the small intestine of the hemizygous APC
D468 mice
as early as 5 weeks of age, most frequently in the distal ileum (Fig.
S1a&b). Colonic polyps were less frequent and increased with age.
Morphologically, the polyps were undifferentiated Fig. S2a&b),
were polyclonal (Fig. S2c), tubovillar (Fig. S2d&e), and were
composed of tall hyperchromatic disorderly cells with cigar-shaped
nuclei (Fig. S2f).
Closer histological examination revealed a rich infiltrate of
hematopoietic cells, including granulocytes, mast cells, plasma cells,
and lymphocytes (Fig. 1a–d). Two distinct populations of myeloid
cells were significantly increased in the lesions: CD11b
+GR1
+
(MDSC), and CD11b
+F480
+ macrophages (Fig. 1B&C). The
MDSC infiltrate increased with age and tumor load (Fig. 2Aa
compare with2Ab; 2Ba&b),while macrophage density was elevated
abruptly and remained high (Fig. 2Ac compare with 2Ad; Bc&d). In
contrast, the intestine of ageing wt mice showed little infiltration by
MDSC, and had delayed increase in macrophages (Fig. 2B, black
bars). As the APC
D468 mice aged, anemia and systemic inflamma-
tion developed contributing to a notable increase in the size of the
spleen (Fig. S3a), which was in part accounted for by infiltrating
MDSC and macrophages (Fig. S3b&c).
Near infra red mechanism-based probes accurately mark
areas of dysplasia
Aged mice showing early signs of cahexia were injected with the
ProSense 680 (2 nmoles/mouse) 24 hours before the imaging
session. To image angiogenesis we employed the constitutively
emitting AngioSense 750 probe and injected the mice just before
the imaging session.
Mice were anesthetized, a short loop of the small bowel was
surgically exposed and individual polyps together with surround-
ing tissue as well as healthy bowel tissue were imaged with the
prototype Olympus IV 100 scanning LASER intravital micro-
scope. Images were collected using dry 64 and 610 lenses in z-
stacks, from the tips of the luminal border towards the submucosa.
After spectral separation, three channels, namely 694 nm,
790 nm, and 505–510 nm, were used to collect images from the
cathepsin inducible ProSense 680 (Fig. 3a&b), the vascularity-
contrasting agent, AngioSense 750 nm (Fig. 3c&d), and auto-
fluorescense (Figure 3e&f) respectively. Images were recorded from
1 mm thickness sections, down to more than 100 sections depth.
The collected composite files of the z-stacks were analyzed with
the Image J software.
In healthy bowel, the ProSense 680 image revealed a canonical
honeycomb-like distribution of the signal depicting the axial image
of the intestinal villi (Fig. 3a). The AngioSense 750 (Fig. 3c) and
auto-fluorescence at 505–510 nm revealed similar honeycomb
distributions, tracing the blood vessels and stroma (Fig. 3e). The
image of micro-adenomas was drastically different, with broad
areas of high signal intensity demarcating areas of dysplasia
(Fig. 3b), and rich arrays of micro-vessels supplying the lesions.
Inside the tumor, the vessels expanded into large dead-end
structures typical of mother vessels that are often characteristic of
tumor vasculature (Fig. 3d) [17,18]. Tumor stroma was strongly
autofluorescent (Fig. 3f, Fig. S4).
The increased signal of the ProSense 680 in microadenoma is
attributed to increased local cathepsin activity. To demonstrate
this, we imaged microdenoma 24 hours after injecting mice with
2 nmoles ProSense 680 and 2 nmoles ProSense-control 750. The
Prosense-control 750 cannot be hydrolyzed by cathepsins and the
Figure 1. Infiltration of polyps by pro-inflammatory cells. (A)
Histology of polyps from APC
D468 mouse. (a–b) CEA stained paraffin
sections counterstained with Gill’s II Hematoxylin; (c&d) methylene blue
staining; arrows point to (a) granulocytes, (b) mast cells, (c) plasma cells,
(d) lymphocytes. (B) Immuno-fluorescence of polyps from APC
D468 mice.
Cryosections were stained with (a) DAPI, (b) CD11b-AlexaFluor 488, and
(c) Gr1-AlexaFluor 594. Arrows point to polyp, and arrowheads to the
adjacent healthy villus; note accumulation of CD11b
+ cells and/or Gr1
+
cells in the polyps. (C) FACS analysis of leukocytes prepared from micro-
dissected polyps, and from adjacent tissue (n=4), and of intestinal
tissue from age-matched healthy control mice (n=3). Mean values and
SEM are shown for frequencies of CD11b
+ and of CD11b
+Gr1
+ cells in 6
month-old mice.
doi:10.1371/journal.pone.0002916.g001
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poly-D-lysine. Accordingly, while the ProSense 680 signal was
readily visible within microadenoma (Fig S5a) the ProSense
control 750 failed to become activated (Fig. S5b; see merged Fig.
S5a). In a typical experiment, the ratio of the mean intensities of
the ProSense 680 to ProSense control 750 throughout the z-stack
within a polyp was 4961.4 (168 slices, 1 mm/slice), while in the
adjacent healthy tissue this ratio was 2.160.01 (p,0.0001 one
tailed t test with Welch correction, n=168 slices) (Fig. S5d). These
observations strongly suggest the specific activation of Prosense-
680 through proteolytic cleavage.
To investigate whether the increased signal was due to more
activity per cell ora greaternumberof cells with thesameindividual
activity, we analyzed the volume and total intensity of the ProSense
680
+ particles. Their mean volume in the polyp z-stack
(1289006104800 mm
3, n=92) was over 28 times that in the
healthy intestine (45386797.5 mm
3, n=81, Fig. 3g). The increase
in total intensity of the ProSense-680
+ particles was directly
proportional to the increase in volume of signal (Fig. 3i; 1/
slope=0.004540 for the APC
D468 polyps r
2=1, total number of
values 51, and 1/slope=0.004539 for the healthy intestine
r
2=0.9999, total number of values 60), suggesting that the increase
in signal intensity was due to an increase in the numbers of
cathepsin active cells. In agreement with this conclusion, we found
no significant difference in the ‘‘specific intensity’’ (intensity per
mm
3) of the particles found in APC
D468 mice (242.960.01 units/
mm
3), and in wt mice(242.260.413 units/mm
3), the P value between
the sets being 0.1233 in the unpaired t test with Welch’s correction
(the values of the size of the particles and their intensity were
collected from the original 16-bit image). Furthermore, it was
obvious that the centers of the ProSense-680
+ particles were
distributed throughout the acquired slices of z-stacks, and were
uniformly larger in volume and therefore brighter by about 2 orders
of magnitude in the polyps (1.321*10
768.873*10
6) as compared to
the healthy surrounding tissue (859261257) (Fig. 3j; Suppl Video
S1). Similar analysis of AngioSense-750 showed that the mean
volume of the vessels in polyps was nearly 2.5 times higher
(1127063207 mm
3, n=101) than the mean volume of the vessels in
the normal intestine tissue (45386798 mm
3, n=81, Fig. 3h). Thus,
increased vessel volume provides an independent means of
visualizing early dysplasia, in accordance with published literature
that links cathepsin activity with neovascularization [11
,19,20].
ProSense 680 is activated by MDSC and macrophages
To reveal the cellular source of cathepsin activity, APC
D468
mice were stained in vivo by injecting i.v ProSense-680 24 hours
prior to being sacrificed. The entire gut was then excised, washed,
fixed and embedded in OCT and frozen for histology and
immunofluorescence analyses. Immunofluorescence staining re-
vealed overlap of both CD11b (AlexaFluor 488) and Gr1
(AlexaFluor 594) with ProSense-680 signal (Fig. 4a–e), in cells
that were dispersed through out the polyp stroma. The Image J
‘‘colocalization finder’’ in conjunction with the ‘‘nucleus counter’’
plug-in was utilized to analyze the fluorescent images. Figure 4d
shows the result of the co-localization between the ProSense-680
+
(red) and CD11b
+ (green) fluorescent images. Co-localized pixels
were revealed as white spots, and correspond to the 22/42
CD11b
+ cells and 22/36 ProSense 680
+ cells. Figure 4e is the
outcome of the colocalization analysis between ProSense-680
+
(red) and the Gr1
+ (green) fluorescent images. Again, co-localized
pixels were revealed as white spots, and this time correspond to the
11/45 Gr1
+ cells and 11/36 ProSense-680
+ cells.
To further characterize cathepsin probe-active cells, total
Mono-Nuclear Cells (MNCs) were prepared from intestine of 5-
month-old APC
D468 mice. These were incubated ex vivo with
0.2 nmoles/ml ProSense-680 for one hour and after cell surface
staining subjected to FACS analysis. MDSC and macrophages
accounted for over 75% of the ProSense
+ MNCs (Fig. 4f&g).
Altogether, 1160.69%, of the living cells (mice n=6) were stained
with the cathepsin activated probe, of which 3.460.6 were MDSC
and 5.060.34% macrophages (Fig. 4i). For control, the MNCs
were incubated with 50 mg/ml JPM-565 that is a general
cathepsin inhibitor in RPMI 1640 for an hour at 37uC in the
presence of 5% CO2 and then stained with 0.2 nmoles/ml
ProSense 680. This resulted in a marked reduction in the intensity
Figure 2. Flow cytometric analysis of polyp infitrate. (A) FACS
analyses of pro-inflammatory cells. (a) Exemplar FACS analyses of
mononuclear cells prepared from the intestine of (a&c) a 5 month-old
APC
D468 mouse and (b&d) an age matched wt C57BL/6J mouse; note
increases in the frequencies of (a) CD11b
+Gr1
+ and (c) CD11b
+F4/80
+
myeloid type cells in the polyposis intestine, compared to wt tissue
(b&d respectively). (B) Summary of FACS analysis of MNCs from wt
(black bars) or APC
D468 (open bars) intestine, showing mean frequencies
and absolute numbers of cells with SEM values; n=6 for APC
D468,n=3
for wt control mice, per age group.
doi:10.1371/journal.pone.0002916.g002
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+ cells by Prosense 680 (Fig. S6a). In a typical
experiment the frequency of ProSense 680+ cells was reduced
from 3.49% to 1.59% (Fig. S6b). This result indicates that
cathpesin activity was responsible for the ex vivo staining of
myleloid cells by Prosense 680.
Cathepsin activity reports focal inflammatory reactions in
dysplasia
To relate the signal to cathepsin activity, we quantified the
amounts of active cysteine proteases of the cathepsin family in the
polyps as compared to healthy surrounding tissue, and control
healthy intestines. To quantify specific protease activity, we used
DCG-04, a biotinylated derivative of the non-specific cathepsin
inhibitor JPM-565 that interacts with the active site of cysteine
cathepsins [21,22]. Tissue extracts from micro-dissected polyps
and from healthy intestine tissues were incubated with DCG-04,
and individual cysteine cathepsins were then identified by their
relative molecular weights, after separating the extracted proteins
by SDS-PAGE. This inhibitor has been used previously to
measure active cathepsins B, S, L and Z (also known as cathepsin
X) in cell extracts [21,22]. We used extracts from Cathepsin B
deficient mice [23,24] as control. Comparing values from 6 mice
per group confirmed significant (P,0.0001) up-regulation of active
cathepsin B in polyps (175906883 OD units) compared with
neighboring tissue (77986993 OD units), or from intestines of
healthy age-matched mice (68796651 OD units)(one tailed t test
with Welch correction) (Fig. 5a). Treatement with anti-TNFa
caused a significant drop in the levels of polyp specific active
cathepsin B (70476194 OD units; P,0.0001).
Similarly, we detected elevated levels of cathepsin Z in polyps
(98866971 OD) as compared with adjacent tissue (33626752 OD
units; P=0.0005) or with wt intestine tissue (22656595 OD units;
P=0.0005) (one tailed t test with Welch correction). In accordance
with previous reports [25], levels of active cathepsin Z were
elevated in in the intestine of Ctsb
2/2 APC
D468 mice (63646629
OD units) as compared to wt intestine (22666595 OD units)
(P=0.0179,t test with Welch correction). We were unable to detect
cathepsin L and S. Cathepsin L has been reported to be unstable
in extract [26].
Live Imaging of Cathepsin B activity Reveals Dynamics of
Polyp Growth/Regression
These observations led us to conclude that the ProSense-680
signal was reporting cancer-associated inflammation. We had
previously reported that treatment of APC
D468 mice with anti-
TNFa results in suppression of established polyps [27]. To assess
Figure 3. In vivo molecular imaging of polyps in APC
D468 mice. A small loop of the intestine of each APC
D468 and wt animals was surgically
exposed and underwent laser scanning Intravital Fluorescent Microscopy (IVFM) 24 hour after injection with the ProSense-680. ProSense-680 image
of cathepsin activity in (a) healthy intestine, (b) APC
D468 polyp. AngioSense 750 image of vasculature in (c) healthy intestine, (d) APC
D468 polyp.
Spectrally resolved auto-fluorescence of (e) healthy intestine, (f) APC
D468 polyp at 505–510 nm. Z-stack slice 42 for the healthy intestine and slice 51
for the APC
D468 polyp were imaged using an UplanApo 106objective with 26electronic zoom (pixel size 1.05 mm with resolution 2.42 mm). (g) The
mean volume of particles visualized at 694 nm (ProSense-680); green bar represents APC
D468 polyps (128,9006104,800 mm
3 (n=92)), red bar healthy
intestine (4,5386797.5 mm
3 (n=81)). (h) The mean volume of particles visualized at 790 nm (AngioSense-750); green bar represents vasculature in
polyps (1127063207 mm
3, n=101), red bar represents vasculature in healthy intestine (45386798 mm
3, n=81). Calculated with the Image J ‘‘3D
particle analysis’’ plug-in. (i) Linear regression, correlating the size of ProSense-680 particles in polyps (green dots, 1/slope=0.004540, r
2=1) with
those in healthy intestine (red dots, 1/slope=0.004539, r
2=0.9999); note that the increase in intensity corresponds to the increase in the number of
cathepsin active cells. (j) ‘‘Calculated centers of intensity’’ of particles in the z-axis of the APC
D468 adenoma (green diamonds) and healthy intestine
(red triangles); note distribution throughout the z- stack, and that the total intensity of the particles in the APC
D468 adenoma is at least 2 orders of
magnitude higher (mean total intensity 1.322610
768.881610
6 units) than the particles in the wt intestine (mean total intensity 859261257 units,
P,0.0001 one sample t test).
doi:10.1371/journal.pone.0002916.g003
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of cathepsin B [23,24]. with treatment of mice with anti-TNFa.
Towards this end, we crossed APC
D468 mice to cathepsin_B
deficient mice. Western blot analysis with DCG-04 confirmed that
polyps arising in cathepsin-B ablated mice were specifically devoid
of cathepsin B activity (Fig. 5a&b), while cathepsin Z was not
significantly altered. Interestingly, polyps of anti-TNFa treated
mice also showed a selective decrease in cathepsin B, as compared
to Z (Fig 5a&b).
Both ablation of cathepsin B and treatment of mice with anti-
TNFa significantly reduced polyp density and size. Cathepsin B
deficient mice had less polyps (3962.1 adenoma of Ctsb
2/2
APC
D468 mice n=8, compared to 9463.5 adenoma for APC
D468
n=16, P,0.0001 unpaired t test with Welsh correction), which
had the trend to have smaller size (1.8260.11 mm diameter for
Ctsb
2/2 APC
D468 mice n=8, compared to 2.04760.11 mm
diameter for APC
D468 n=16, P=0.086) (Fig. 6a). Anti-TNFa
treated mice also showed reduced numbers (34.364.49 adenoma,
n=8,P,0.0001, unpaired t test with Welsh correction) and sizes
of polyps (1.51660.022 mm in diameter, P,0.0001 unpaired t
test with Welsh correction, n=6) (Fig. 6c) as compared to
untreated APC
D468 mice.
FACS analysis revealed that intestines of Ctsb
2/2 APC
D468
mice harbored 40% less ProSense-680
+ MNCs (6.7%6086%), as
compared to the APC
D468 (11%60.69%, P=0.0037, Fig. 6b).
This reduction can be attributed to a drop in the levels of MDSCs
with ProSense-680 activity (mean frequency 0.56% as compared
to 4.46%; P=0.0085, n=6, unpaired t test with Welsh correction,
Fig. 5c). The frequencies of ProSense-680
+, CD11b
+F4/80
+ cells
remain unchanged (mean 5.36% to 5.03% respectively). MDSC
density was also markedly reduced in anti-TNFa treated mice
Figure 4. The cellular source of cathepsin activity. Cryosections of ProSense-680 in vivo stained intestine from APC
D468mice were stained with
antibodies to CD11b (AlexaFluor 488), Gr1 (AlexaFluor 594) and DAPI. The merged images of CD11b with DAPI (a, CD11b green, DAPI gray), Gr1 with
DAPI (b, Gr1 red, DAPI gray), and ProSense-680 with DAPI (c, ProSense-680 blue, DAPI gray) were produced with the ‘‘RGB gray’’ plug-in of Image J.
The ‘‘colocalization finder’’ plug-in produced images where the colocalized pixels appear white while the ProSense-680 was red (d&e), the CD11b was
green (d, colocalization analysis of ProSense-680 and CD11b staining) and the Gr1 was green (e, colocalization analysis of ProSense-680 and Gr1
staining). 6400 magnification. Arrows mark a CD11b
+Gr1 ProSense 680
+ cell. Representative FACS dot-plots of MNCs prepared from polyposis
intestine and ex vivo stained with ProSense-680 followed by CD11b and Gr1 staining. The live MNCs were gated for ProSence-680
+ cells, which were
analyzed for CD11b
+Gr1
+ (f, MDSCs) and CD11b
+ F4/80
+ (g, macrophages) cells. Cumulative results of 6 FACS experiments showing % of CD11b
+Gr1
+
ProSense-680
+ and CD11b
+F4/80
+ProSense 680
+ among total infiltrating MNCs. Note that among the ProSense-680
+ cells (1160.69% of total MNCs)
over 75% were either CD11b
+Gr1
+ (3.460.6% of total MNCs) or CD11b
+F4/80 (5.060.34% of total MNCs).
doi:10.1371/journal.pone.0002916.g004
Figure 5. Quantification of active cysteine cathepsins using a
specific active site directed probe. Polyps from APC
D468, Ctsb
2/2
APC
D468, and anti-TNFa treated APC
D468 mice were micro-dissected,
pooled, and extracts were incubated with DCG-04 prior to electropho-
resis on a 4–12% gradient SDS gel and western blotting; healthy
adjacent regions were similarly analyzed. Active Cathepsins were
visualized with the use of chemiluminescence reagents. (a) A
representative blot. (b) Average Optical Densities (OD) from each band
of three independent blots, measured with Image J software; values
were normalized with the OD of the b-actin protein, detected using a
specific antibody. Open bars: Cathepsin Z, black bars: Cathepsin B.
doi:10.1371/journal.pone.0002916.g005
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significant drop in frequency (Fig 6f).
To relate changes in ProSense-680
+ MNCs in treated mice with
changes in in situ imaged fluorescent signal, we imaged polyps from
these mice and analysed the z-stacks in a quantitative manner. The
volumes of cathepsin ProSense-680
+ particles were significantly
smaller in Ctsb
2/2 APC
D468 polyps (mean volume
2660965268 mm
3, P,0.0001, one sample t test, Fig. 7 g&c) and
polyps in anti-TNFa treated APC
D468 mice (mean volume
863961570 mm
3, P,0.0001, one sample t test, Fig. 7 g&e) as
compared with polyps in age matched APC
D468 mice (mean
volume 120554686906 mm
3, Fig. 7 g&a). The numerical results
are in accordance with the optical impression of the images, and
with the intesity of signal being higher in APC
D468 than Ctsb
2/2
APC
D4688 and the anti-TNFa treated APC
D468 (Fig 7).
The mean volume of the vessels stained with AngioSense 750
was 2.2 times smaller in Ctsb
2/2 APC
D468 adenoma
(696361236 mm
3, Fig. 7 d&h), and 4.2 times smaller in the anti-
TNFa treated APC
D468 adenoma (370061444 mm
3, Fig. 7 f&h),
as compared to the polyps in APC
D468 mice (1550162144 mm
3,
Fig. 7 b&h).
These observations indicate that near infra red activity-based
ProSense-680 accurately marks areas of dysplasia, preferentially
reports cathepsin B activity, and reveals biological activity directly
linked with the progression or regression of the polyps.
Furthermore, the AngioSense 750 signal provided us with
independent confirmation of tumor associated angiogenesis, the
location of dysplasia, and biological response to treatment.
Discussion
Endoscopic techniques have provided sensitive means of
detecting adenomatous polyps that could potentially progress to
colon cancer. Thus, endoscopic monitoring of susceptible
individuals has made it possible to detect and remove early
dysplastic lesions before they become life threatening. To date,
visualization of the dysplasia has been limited to detection of
anatomical abnormalities, and there is no precedence of live
imaging of biological activity that is predictive of tumor growth
versus regression. In this study we have shown that cathepsin B
activity is an inherent component of cancer-associated inflamma-
tion in tumor infiltrating myeloid cells. We have demonstrated that
live imaging of this activity is feasible, and provides for accurate
demarcation of dysplasia and the associated neo-angiogenesis.
Furthermore, we have demonstrated that this mode of imaging
reveals dynamics of biological activity that is predictive of tumor
progression versus response to therapy.
Cathepsin B activity has been associated with a number of
tumors in humans and experimental animals, making it an
attractive avenue for the imaging and possible treatment of cancer
[10,19,20]. Here we provide evidence that in addition to cathepsin
B, another member of the cysteine family of cathepsin Z is
significantly up regulated in adenomatous polyps. Cathepsin
activities were focal and readily distinguished the dysplastic lesions
from the healthy neighboring tissue. Thus, imaging of this activity
Figure 6. Cathepsin B deficiency or anti-TNFa treatment
attenuate polyposis. (a) Non-linear regression analysis of polyp
number and diameter, assuming Gaussian distribution; APC
D468 Ctsb
2/
2 (continued line, open squares), and APC
D468 (dotted line, closed
triangles). Note that Cathepsin B
2/2 mice had fewer and smaller polyps.
(b) Frequencies of ProSense-680 active leukocytes amongst total MNCs
prepared from the intestine of APC
D468 (open bar, 6.7%6086%) or
APC
D468Ctsb
2/2 (filled bar, 11%60.69%, P=0.0037; unpaired t test with
Welsh correction). (c) Frequencies of ProSense-680 active CD11b
+Gr1
+
(mean 0.56%) or CD11b
+F4/80
+ (mean 4.46%) cells, from the intestines
of APC
D468 (open bar) and APC
D468Ctsb
2/2 mice (filled bars); P,0.001,
n=6, 2way ANOVA. Note that Cathepsin B deficiency predominantly
impacted the abundance of CD11b
+Gr1
+ cells. (d) Attenuation of
polyposis in anti-TNFa treated mice (solid line, open squares, n=6), as
compared to the APC
D468 (dotted line & closed triangles). (e)
Frequencies of CD11b
+Gr1
+ amongst total intestine live MNCs;
APC
D468Ctsb
2/2 intestine (light gray bar, 0.5660.15%, P,0.001), anti-
TNFa treated (dark gray bar, 0.7160.22%, P,0.001), untreated APC
D468
(open bar, 4.260.093%), wt control intestine (black bar, 0.1560.051%).
(f) Frequencies of CD11b
+F4/80
+ in the APC
D468 (5.0360.78%),
APC
D468Ctsb
2/2 intestine (5.3660.92%), and anti-TNFa treated intestine
(dark gray bar, 3.060.67%).
doi:10.1371/journal.pone.0002916.g006
Figure 7. Imaging polyps in mice deficient for Cathepsin B or
responding to effective anti-TNFa therapy. Spectral separation of
images from, (a&b) APC
D468 mice, (c&d) Ctsb
2/2APC
D468, (e&f) anti-
TNFa treated APC
D468 mice; ProSense-680 (green; CathepsinB), Angio-
Sense-750 (red; blood vessels). The objective used was the UplanApo
46 (pixel size 5.4 mm, lateral resolution 12.42 mm). (g) Mean particle
volumes in the Z stacks of fluorochrome 680 (open bar: APC
D468,
120554686906 mm; gray bar: APC
D468Ctsb
2/2, 2660965268 mm
3; anti-
TNFa treated APC
D468, 863961570 mm
3;P ,0.0001 one sample test). (h)
Mean particle volumes in the Z stacks of fluorochrome 750 (open bar:
APC
D468, 1550162144 mm
3;g r a yb a r :A P C
D468Ctsb
2/2,
696361236 mm
3, anti-TNFa treated, 370061444 mm
3;P ,0.0001 one
sample test).
doi:10.1371/journal.pone.0002916.g007
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of dysplasia that may be undetectable by visible light imaging, due
to size limits or anatomical features.
The source of cathepsin activity in tumors has been in the past
debated, with some reports emphasizing that tumor cells are the
major source of this activity. Here, we provide evidence based on
histology and flow cytometry that clearly reveals tumor infiltrating
myeloid lineage cells as the predominant source of this activity.
This is a fortunate and useful finding, as cancer-associated
inflammation is causatively linked with adenoma growth.
Significantly, our analysis of fluorescent signals detected with in
the lesions revealed that the local increase in signal intensity was
due to increased numbers of cathepsin active cells rather than
higher activity per cell. Furthermore, we could confidently and
accurately detect this activity to a depth of at least 75 mm. Thus,
the imaged signal was directly reporting the abundance of pro-
inflammatory cells within the dysplasia.
We demonstrated that genetic ablation of cathepsin B results in
suppression of tumor infiltrating pro-inflammatory cells, notable
attenuation of polyposis, and a decrease in the fluorescent signal
emanating from the lesions. Ablation of cathepsin B significantly
increased the overall levels of active cathepsin Z, Previous reports
suggest that cathepsin Z (also called cathepsin X) compenstates for
the levels of membrane bound cathesin B, and is elevated in
cathpesin B knock out mice [25]. Thus, attenuation of probe signal
in polyps arising in cathepsin B knock mice suggests that the probe
activity was relatively specific for cathepsin B. Furthermore,
attenuation of polyposis in these mice suggests a specific
requirement for cathepsin B in the progressive growth of polyps.
Surprisingly, cathepsin B deficiency predominantly affected the
CD11b
+Gr1
+ MDSC infiltrate, and did not impact the
CD11b
+F480
+ macrophage component of polyp infiltrating
leukocytes. Both of these myeloid cell types contributed equally
to the local activation of the ProSense 680 probe. Since
preferential loss of MDSC correlated with polyp attenuation, we
conclude that these cells were critically contributing to the
progressive growth of dysplasia. Furthermore, we conclude that
the decrease in cathepsin activated probe signal was largely due to
the loss of MDSCs from areas of dysplasia.
The cytokine TNFa is regarded to be at the apex of inflammatory
responses, promoting angiogenesis, mobilization of neutrophils and
escalation of inflammation [28,29], including cancer associated
inflammatory reactions [30]. Treatment of mice with anti-TNFa
suppresses pathogen induced inflammatory bowel disease and
inflammation triggered cancer [27,31,32]. We therefore postulated
that if pro-inflammatory cells were the source of cathepsin activity
and played a causative role in polyposis, then suppression of
polyposis-associated inflammation should hinder progressive polyp
growth,and this therapeuticeffectshouldbe reflected ina significant
down-regulation of cathepsin activity. Treatment of mice with anti-
TNFa resulted in a preferential loss of MDSC infiltrating the lesion,
in increased apoptosis of the aberrant epithelial cells, and regression
of the lesions. Accordingly, cathepsin-B activities as measured by
western blot analysis and probe signal were significantly attenuated.
Altogether, these observations establish live imaging of cathepsin B
activity with sensitive near infrared probes as a highly specific
method for detection of biological activity linked with progressive
tumor growth.
Tumor associated neo-angiogenesis is considered to be a
necessary pathological component of tumor growth and a viable
target for therapeutic intervention. Pro-inflammatory cells are a
recognized source of angiogenic factors, and suppression of
inflammation is therefore expected to impact tumor associated
inflammation. It is not known at what stage dysplasia triggers
angiogenesis and how the dynamics of infiltrating leukocytes
reflect the expansion or regression of blood vessels in the lesion.
Here, taking advantage of a constitutively active near infrared
probe we have imaged in a living animal the neo-vascularization of
early dysplastic lesions by micro-vessels, and revealed the change
in architecture of the vasculature entering the lesion. Using
different fluorescent excitation and spectral separation of the
images we succeeded in simultaneously imaging both angiogenesis
and cathepsin B activity in the same tissue and 3-dimensional
space. The visualization of the architecture of the lesion was
further enhanced by concomitant imaging of auto-fluorescent
signals that emanated largely from the tumor mucosa
We were able to demonstrate that anti-inflammatory regiments
such as ablation of cathepsin B or treatment of mice with anti-
TNFa impacts the infiltration of dysplastic lesions by the
microvasculature, and that loss of the vessels correlates with
attenuation or regression of the lesions. Thus, near infrared
imaging of blood microvasculature provides an independent
means of monitoring progressive dysplasia, and response to
effective therapeutic intervention.
In summary, we have shown that live imaging of mechanism-
based near infrared probes allow simultaneous detection of
independent biological activities that report progressive tumor
growth. Our earlier studies have documented the feasibility of
application of this mode of imaging to endoscopic monitoring of
cancerous lesions. Here, we have provided mechanistic informa-
tion on the source and biological significance of the signal. All
together, we have documented a powerful advance in our
visualization of tumor biology dynamics, which allows for sensitive
monitoring cancer progression or favorable response to therapy.
Materials and Methods
Microscope and the operational organization
The prototype Olympus IV 100 LASER scanning intravital
microscope was used to collect images from living tissues. This
microscope has 4 lasers that with the use of a specialized array of
filters can excite a wide variety of fluorochrome including the
Cy5.5 (max excitation 680 nm, excited in this microscope with the
633 nm LASER, emission 680 nm) and Cy7 (excitation 749 nm,
emission 790 nm). For this study the 46 and the 106 dry
objectives were used. The emissions were separated in the desired
spectrum through a set of mirrors and filters and collected from 3
Photomultipliers (PMT). Olympus FlowView software is used to
compensate the channels and collect the FlowView images.
The microscope uses motors controlled by the software for the
collection of the z-stacks used in this report. A 37uC table was
available for the comfort of the anesthetized animals during
operation.
Live imaging probes
To visualize in detail the cathepsin activity and its distribution
along the intestine three probes were utilized, the ProSense 680
(ProSense 680), ProSense control 750 and a high molecular weight
(250,000 g/molecule) probe linked with fluorochrome that is
excited at 750 nm and emits at 790 nm (AngioSense750).
ProSense 680 is a composite probe that is based on a poly-lysine
chain on which a number of fluorochrome molecules were linked
on the side chain of the lysine moiety, as well as a number of
MPEG molecules. The composite probe with the poly-L-lysine
backbone intact does not emit fluorescence because of quenching,
but when the backbone is hydrolyzed by cathepsins the
fluorochrome emits a strong signal. ProSense control 750 has a
poly-D-lysine backbone that cannot be hydrolysed by cathepsins
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the non specific quenched accumulation of fluorescent dyes in
areas of high vascularity. AngioSense 750 remains in the vessels
during the normal experimentation period and delineates the
vessels. The autofluorescent signal (505–510 nm) was used to
visualize the outline of the tissue imaged.
Mouse studies
Cathespin B knock-out mice have been reported before and
were a kind gift [23,24]. Throughout the procedures in which
animals were injected with the probe, as well as during the
imaging session, mice were anaesthetized with inhalation of 1.5–
2% mixture of Isoflurane in oxygen.
Mice were retro-orbitally injected with the ProSense-680
24 hours before the experimental procedure (2 nm/mouse,
150 ml). Ten minutes before the imaging session the mice were
injected with 100 ml of the AngioSense-750. According to our
observations most of the probe remains in the vessels for at least
1 hour.
Mice were incised and a loop of the intestine was cut along the
length and opened to allow imaging in z stacks from the inside out.
The mice were constantly monitored for the rate of the respiration
and the depth of their anesthesia. The typical imaging session has
duration of 60–90 min. throughout the imaging session the mouse
is alive and anaesthetized.
All animal experiments were approved by the Harvard Medical
School Standing Committee on Animals (protocol 04084, Dr K.
Khazaie), by the Dana Farber Cancer Institute IACUC (protocol
02033, Dr Khazaie) and the Northwestern University Animal
Study Protocol 2007-1284 (Dr Khazaie) for ‘‘imaging proteolytic
activity in colon cancer’’.
Imaging analysis software
The collected z-stacks were in the form of multiple ‘‘. tiff’’
FlowView files and can be seen and split into channels with the
USDA plug-in collection of ImageJ open source software. To
analyze the particles we used the bundle of plug-in developed by
the Bob and John Wright Cell Imaging Facility of the University of
Ontario Canada (http://www.uhnresearch.ca/facilities/wcif/
fdownload.html). Several other stack plug-ins were utilized.
Statistical analysis
Any values referred to as statistically analyzed are expressed as
‘‘mean value6SEM’’. We consider a P value between groups to be
significant if P,0.05.
For the preparation of Fig. 3i we employed Linear Regression
Analysis to correlate the size of the particles with their total
intensity. We used unpaired t test with Welsh’s correction analysis
to correlate the sets of values of intensity per voxel in the particles
of the APC
D468 adenoma and the wt images, for the comparison of
the frequencies of the ProSense-680
+ stained leukocytes (Fig. 6b)
and the correlation of the frequencies of the MDSCs ProSense-
680
+ cells in APC
D468 and wt MNCs. We employed one sample t
test to compare the size of the ProSense-680
+ particles of APC
D468
adenoma with the ProSense-680
+ particles in Ctsb
2/2 APC
D468
and TNFa treated APC
D468 polyps because the size of particles
was very diverse in all samples (Fig. 7).
For the preparation of Fig. 6a&c we employed Non-Linear
Regression Analysis to correlate the size of the polyps with their
number assuming that the size distribution is Gaussian. The non-
linear regression graph was superimposed with the actual values of
the size and the numbers of the polyps in each individual mouse.
‘‘Prism 4’’ software was used for all these analyses, and the related
graphs.
Immunofluorescence analysis
Mice were stained in vivo for 24 hours with 2 nm ProSense-
680. The following day were sacrificed and the fillet-opened
intestine was rolled and frozen in OCT. Cryosections were
prepared (15 mm) and fixed in acetone (220uC, 15 min),
rehydrated in PBS and incubated with the primary antibodies
(biotinylated anti-CD11b, 1:75, and purified rat anti-Gr1, 1:75)
antibodies for one hour. The slides were washed in PBS (365 min
each) and incubated with the secondary antibodies (streptavidin
AlexaFluor 594, and anti-rat IgG AlexaFluor 488, 1:75 each).
After an hour the sections were washed with PBS and mounted
with antifade mounting solution that contains DAPI. A specific
filter was utilized to visualize the Cy5.5 fluorochrome
Supporting Information
Figure S1 Distribution of adenomas in the APC
D468 intestine. (a) the
number of polyps plotted against their location throughout the
length of the small intestine of 3 month-old mouse. (b) Typical
distribution of polyps along the length of the small intestine. (c)
Number of polyps as a function of age of mice, plotted in three size
groups. (d) Number of polyps as a function of age of mice.
Found at: doi:10.1371/journal.pone.0002916.s001 (3.76 MB TIF)
Figure S2 Histological properties of APC
D468 polyps. (a) b-galactosi-
dase staining APC
D468 adenoma. (b) PAS staining of a 6 mm
paraffin section of an APC
D468 adenoma. The arrow indicates the
characteristic purple staining of the mucus inside the goblet cells.
(c) X-gal staining of TS4cre APC
lox468 R36R polyp; (d) H&E
staining of a jellyroll preparation of an APC
D468 intestine.
Magnification 506. The arrow indicates a large adenoma. (e)
1006 magnification of an area of the same section. The arrow
indicates a small adenoma and the arrowhead a normal villus. (f)
4006 magnification of the area surrounded with the white
rectangular in (e). The arrow indicates an adenoma.
Found at: doi:10.1371/journal.pone.0002916.s002 (3.95 MB TIF)
Figure S3 Systemic inflammation in the APC
D468 mice. (a) Increase in
the weight of the spleen as the mice age (blue dots) as compared to
the wt spleen weight (red dots) (P=0.0003). The CD11b
+Gr1
+ (b)
and the CD11b
+F4/80
+ cell numbers in the spleen of the
APC
D468(open bars) and the wt (black bars) mice.
Found at: doi:10.1371/journal.pone.0002916.s003 (0.47 MB TIF)
Figure S4 Autofluorescence intensity of the APC
D468 adenoma. The
distribution of the auto fluorescence alongside the z-stack.
APC
D468 adenoma shown in Fig. 3f (black squares) as compared
to the wt equivalent shown in Fig. 3e (open triangles).
Found at: doi:10.1371/journal.pone.0002916.s004 (0.30 MB TIF)
Figure S5 Cathepsin activity is required for unquenched ProSense 680
signal in the APC
D468 adenoma.A P C
D468 mice were stained a day
before the imaging session with 2 nmoles/mouse of ProSense 680
and ProSense control 750. Stacks of 168 (1 mm/slice) slices were
collected using the Olympus IV100, the UplanApo 64a n d62.5
electronic zoom using the channels for ProSense 680 and ProSense
control 750. a. merge of the two channels of the160th slice; b. the
ProSense 680 image of the160th slice; c. the ProSense control 750;
d. the ratio of the ProSense 680 to the ProSense 750 signal. The
mean intensity of the adenoma Region Of Interest (ROI, left
rectangular) and the healthy surrounding ROI (right rectangular)
was measured for the both channels in all 168 slices, The bar
diagram shows that the this ratio is 4961.4 for the adenoma ROI
and 2.160.01 for the healthy. The sets of values are statistically
significant (P,0.0001, t test with Welch correction).
Found at: doi:10.1371/journal.pone.0002916.s005 (1.06 MB TIF)
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PLoS ONE | www.plosone.org 8 August 2008 | Volume 3 | Issue 8 | e2916Figure S6 The use of the JPM-565 inhibits the ex vivo staining of the
MNCs with ProSense 680. Isolated APC
D468 MNCs were pretreated
with 50 mg/ml of JPM-565 in RPMI 1640 for an hour in 37uC
and 5% CO2. The positive control remained in the incubator
treated with the carrier of the JPM-565. The cell suspension was
then stained with 0.2 nmoles ProSense 680. The stained cells were
stained with PE anti CD11b antibody and DAPI to detect the
dead cells. a. represents the flow cytometry of the ProSence 680
+
CD11b
+ cells untreated with JPM-565 and b. the treated
equivalent.
Found at: doi:10.1371/journal.pone.0002916.s006 (0.45 MB TIF)
Video S1 Videoofthez-stackofanAPC
D468 adenoma. The stackconsists
of 72 RGB images obtained in three channels. Autofluorescence at
505–510 nm (blue), ProSense-680 at 694 nm (green), and vascularity
contrast enhancing AngioSense-750 at 790 nm (red).
Found at: doi:10.1371/journal.pone.0002916.s007 (4.47 MB
MOV)
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